Amifostine Impurities

Amifostine is used to protect the kidneys from the adverse effects of the chemotherapy agent cisplatin in patients receiving this medicine for the treatment of ovarian cancer.

veeprho banner
Parent Drug Name Name of Impurity Catalogue No.
Amifostine Amifostine Disulfide Tetrahydrochloride VE009627View CAS 10027-65-3
Amifostine Amifostine Impurity 1 VL6220002View
Amifostine Amifostine Impurity 10 TriHCl VE0012146View CAS
Amifostine Amifostine Impurity 2 VL6220003View
Amifostine Amifostine Impurity 3 VL6220004View
Amifostine Amifostine Impurity 4 VL6220006View
Amifostine Amifostine Impurity 5 (HCl) VL6220007View
Amifostine Amifostine Impurity 6 VL6220008View
Amifostine Amifostine Impurity 7 VL6220009View
Amifostine Amifostine Impurity 8 VL6220010View
Amifostine Amifostine Impurity 9 DiHBr VL6220011View
Amifostine Amifostine Thiol VL6220012View CAS 31098-42-7
Amifostine Amifostine Thiol Dihydrochloride VE009626View CAS 14653-77-1
Amifostine Amifostine Thiol-D6 Ditrifluoroacetate DVE00144View
Amifostine Amiloride EP Impurity B (Sodium Salt) VL4630003View

Amifostine Related Compound

Amifostine is also used to treat dry mouth induced by radiation therapy following head and neck cancer surgery.

References

FAQ

What medical conditions does amifostine treat?

Amifostine is approved to protect against renal (kidney) toxicity. It is used to minimize the nephrotoxic effects of cisplatin therapy for advanced ovarian cancer.

What is the amifostine mechanism of action?

Amifostine protects the DNA from the harmful effects of ionizing radiation and chemotherapeutic drug-associated reactive species. It has anti-mutagenic and anti-cancer effects.

Does amifostine treat peripheral neuropathy?

Amifostine decreased the nociception generated by oxaliplatin in mice, indicating that it might be used to treat oxaliplatin-induced peripheral sensory neuropathy.

Request a quote

10027-65-3: Amifostine Disulfide Tetrahydrochloride

10027-65-3: Amifostine Disulfide Tetrahydrochloride
Catalogue No.

VE009627

CAS No.

10027-65-3

Molecular Formula

C10H30Cl4N4S2

Molecular Weight

412.31 g/mol

Parent drug

Amifostine

IUPAC Name

N1-(2-(2-(2-(3-Aminopropylamino)ethyl)disulfanyl)ethyl)propane-1, 3-diamine tetrahydrochloride

Synonyms

N/A

References

Sci-Hub, Amifostine: The First Selective-Target and Broad-Spectrum Radioprotector. The Oncologist, 12(6), 738–747, 10.1634/theoncologist.12-6-738. (2022). Retrieved June 14, 2022, from Sci-hub.se website: https://sci-hub.se/10.1634/theoncologist.12-6-738

Status

In-stock

ListName

Amifostine Disulfide Tetrahydrochloride

Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url